This inventor holds 2 USPTO granted patents and 4 published patent applications. Top assignees: Revolution Medicines, Inc., Wilmington Trust, National Association, as Agent. Active years: 2024-2026.
Company Filing History:
1 out of 40 
1 out of 3 Years Active: 2024-2026
Title: Zhican Wang: Innovator in Cancer Treatment
Introduction
Zhican Wang is a prominent inventor based in Redwood City, CA (US). He has made significant contributions to the field of cancer treatment through his innovative research and development of mTOR inhibitors. With a total of 2 patents, Wang's work is paving the way for new therapeutic approaches in oncology.
Latest Patents
Wang's latest patent, titled "Methods of Treating Cancer with an mTOR Inhibitor," focuses on the treatment of diseases or disorders, particularly cancer, using mTOR inhibitors. This patent outlines methods for administering specific dosages of mTOR inhibitors to treat subjects with cancer. Additionally, it includes strategies for delaying, preventing, or treating acquired resistance to RAS inhibitors. The patent also discusses methods for managing adverse events associated with mTOR inhibitor administration using tacrolimus.
Career Highlights
Throughout his career, Zhican Wang has worked with notable companies, including Revolution Medicines, Inc. and Wilmington Trust, National Association, as Agent. His expertise in the field has allowed him to contribute to groundbreaking research and development efforts.
Collaborations
Wang has collaborated with esteemed colleagues such as Bojena Bitman and W Clay Gustafson. These partnerships have further enhanced his research and innovation in cancer treatment.
Conclusion
Zhican Wang's contributions to cancer treatment through his patents and collaborations highlight his role as a key innovator in the field. His work continues to inspire advancements in therapeutic strategies for cancer patients.